Investment Thesis
Truffle Capital focuses on financing and nurturing pioneering technologies in Life Sciences (MedTech & Biotech) and Deeptech applied to Finance (Fintech & Insurtech). It acts as a founder in BioMedTech, leads investment rounds, and is proactive in governance. The firm has a strong track record of exits and IPOs, with €500M in assets under management and €1.2B raised since inception.
Stage Focus
Not explicitly mentioned, but seems to focus on early to growth stages, given mentions of founding companies and Series B investments.
Preferred startup development maturity for initial funding deployment.
Sectors & Themes
BioMedTech and Finance/Insurance
Core thematic spaces, technologies, and target market segments of interest.
Check Size Range
€1,000,000 - €6,000,000
Standard financial allocation per investment round.
Outreach & Dossier Intelligence
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...
Investment Team (18)
A
Alain Chevallier
Senior Partner, BioMedTech
A
Alexis Le Portz
Entrepreneur & Investor
A
Antoine Pau
Senior Partner, Life Sciences
B
Bernard-Louis Roques
CEO and Co-Founder
B
Bhavesh Barot
Operating Partner & CBO
B
Bozena Adamczyk
Partner
F
Fanny Brugiere
Director of Investor Relations
F
François Levé
Operating Partner
F
François Romaneix
Senior Partner, BioMedTech
H
Henri Moulard
Chairman & Co-Founder
H
Hélène Meyer
Operating Partner, BioMedTech
J
Jean-François Fourt
Partner
M
Michael Kramer
Team Member
O
Ossama Zouaoui
Senior Partner, BioMedTech
P
Patrick Kron
Chairman
P
Philippe Pouletty
CEO and Co-Founder
P
Philippe Pouletty, M.D.
Co-founder and CEO
V
Vincent Dagommer
Operating Partner, BioMedTech
